Benitec Biopharma, Inc. (BNTC)
8.65
-0.17
(-1.93%)
USD |
NASDAQ |
Oct 23, 16:00
8.64
-0.01
(-0.12%)
After-Hours: 20:00
Benitec Biopharma Market Cap : 297.71M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 297.71M |
| October 22, 2026 | 303.56M |
| October 21, 2026 | 292.54M |
| October 20, 2026 | 311.13M |
| October 19, 2026 | 287.72M |
| October 16, 2026 | 279.12M |
| October 15, 2026 | 291.17M |
| October 14, 2026 | 285.32M |
| October 13, 2026 | 297.02M |
| October 12, 2026 | 312.16M |
| October 09, 2026 | 305.28M |
| October 08, 2026 | 301.15M |
| October 07, 2026 | 309.41M |
| October 06, 2026 | 309.75M |
| October 05, 2026 | 317.67M |
| October 02, 2026 | 309.06M |
| October 01, 2026 | 329.71M |
| September 30, 2026 | 344.17M |
| September 29, 2026 | 335.56M |
| September 28, 2026 | 344.86M |
| September 25, 2026 | 330.06M |
| September 24, 2026 | 331.78M |
| September 23, 2026 | 338.32M |
| September 22, 2026 | 376.86M |
| September 21, 2026 | 374.45M |
| Date | Value |
|---|---|
| September 18, 2026 | 379.27M |
| September 17, 2026 | 390.97M |
| September 16, 2026 | 379.96M |
| September 15, 2026 | 380.31M |
| September 14, 2026 | 415.75M |
| September 11, 2026 | 419.54M |
| September 10, 2026 | 420.57M |
| September 09, 2026 | 427.71M |
| September 08, 2026 | 437.16M |
| September 04, 2026 | 435.61M |
| September 03, 2026 | 427.37M |
| September 02, 2026 | 442.48M |
| September 01, 2026 | 422.90M |
| August 31, 2026 | 418.09M |
| August 28, 2026 | 428.40M |
| August 27, 2026 | 435.27M |
| August 26, 2026 | 442.48M |
| August 25, 2026 | 447.29M |
| August 24, 2026 | 436.64M |
| August 21, 2026 | 463.10M |
| August 20, 2026 | 446.95M |
| August 19, 2026 | 459.66M |
| August 18, 2026 | 442.48M |
| August 17, 2026 | 449.01M |
| August 14, 2026 | 431.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 1.682 |
| Price | 8.65 |
| Earnings Yield | -12.57% |